Smart Pills Market Analysis By Application (Products [Capsule Endoscopy, Drug Delivery], Tools, and Patient Monitoring Software), By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa), And Segment Forecasts, 2014 - 2025
This report can be delivered to the clients within 48 hours
The global smart pills market is expected to reach USD 3.0 billion by 2025 at a CAGR of 15.5% during the forecast period, according to a new report by Grand View Research, Inc. Increase in prevalence of diseases such as colorectal cancer and gastrointestinal disorders, expansion in geographical reach of major players, rising cancer screening awareness programs, and expeditious FDA approvals are prime factors that are expected to drive market growth over the forecast period.
Smart pills have transformed the landscape of small bowel, colon, and gastrointestinal endoscopy by providing a non-invasive and accurate method for visualizing distal duodenum, jejunum, small bowel, colon, gastrointestinal, and ileum. Smart pills are mostly used for screening and treatment of diseases such as colorectal cancer, gastroparesis, gastric ulcers, and gastroesophageal disorders.
Consumers of smart pills mostly include geriatric population, immobile patients, and patients with paralysis. Considering the steady rise in geriatric population around the globe, the demand for advanced medical devices will also increase as they offer a degree of convenience to patients.
Established players in this market are enhancing their portfolio by upgrading existing devices. On the other hand, new players are focused on capturing emerging economies with breakthrough products that are both advanced and affordable.
Further key findings from the report suggest:
The global smart pills market is expected to reach USD 3.0 billion by 2025 at a CAGR of 15.5% during the forecast period, according to a new report by Grand View Research, Inc. Increase in prevalence of diseases such as colorectal cancer and gastrointestinal disorders, expansion in geographical reach of major players, rising cancer screening awareness programs, and expeditious FDA approvals are prime factors that are expected to drive market growth over the forecast period.
Smart pills have transformed the landscape of small bowel, colon, and gastrointestinal endoscopy by providing a non-invasive and accurate method for visualizing distal duodenum, jejunum, small bowel, colon, gastrointestinal, and ileum. Smart pills are mostly used for screening and treatment of diseases such as colorectal cancer, gastroparesis, gastric ulcers, and gastroesophageal disorders.
Consumers of smart pills mostly include geriatric population, immobile patients, and patients with paralysis. Considering the steady rise in geriatric population around the globe, the demand for advanced medical devices will also increase as they offer a degree of convenience to patients.
Established players in this market are enhancing their portfolio by upgrading existing devices. On the other hand, new players are focused on capturing emerging economies with breakthrough products that are both advanced and affordable.
Further key findings from the report suggest:
- Capsule endoscopy is the largest application segment owing to factors such as growth in cancer screening awareness programs, increase in incidence of Crohn’s disease and bowel cancer, and increase in demand for minimally invasive procedures
- North America is the dominant region with the largest revenue share. Wide availability of products, favorable reimbursement policies, increase in government investments in healthcare, and an overall rise in healthcare expenditure support market growth
- Asia Pacific is expected to witness the fastest growth over the forecast period. Factors such as increase in disposable income, mandatory healthcare insurance, and rise in healthcare expenditure are expected to drive the market
- Commercially available smart pills include PillCam Capsule, ABILIFY MYCITE, CapsoCam, and Olympus Endocapsule
- Key players in the smart pills market include Medtronic, Olympus Corporation, Proteus digital Health, MediSafe, and CapsoVision
CHAPTER 1 EXECUTIVE SUMMARY
1.1 Market segmentation & scope
CHAPTER 2 RESEARCH METHODOLOGY
2.1 Information procurement
2.2 Data Analysis
2.3 Approaches for market estimation
2.3.1 Approach 1: Demand Analysis & Bottom up Approach
2.3.2 Approach 2: Top down market estimation
2.3.3 Approach 3: Commodity flow and bottom up market estimation
2.3.4 Approach 4: KoL perspective based market sizing
CHAPTER 3 SMART PILLS MARKET VARIABLES, TRENDS, & SCOPE
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.1.1 Increasing incidences of diseases such colorectal cancer and gastrointestinal disorders
3.1.1.2 Increasing geographical reach by major market players
3.1.1.3 FDA approvals and CE Mark for smart pills
3.1.1.4 High Cancer screening awareness programs
3.1.2 Market Restraint Analysis
3.1.2.1 Technological limitations
3.1.2.2 Lengthy product approval process
3.1.2.3 Risks associated with the Capsule endoscopy procedures
3.2 Penetration & growth prospect mapping
3.3 Smart Pills - SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.4 Industry Analysis - Porter’s
3.5 Pipeline Development and Clinical Trials
3.8.1 Clinical Trials in Phase
3.8.2 Clinical Trials in Phase 3 Or 3/2B
3.8.3 Clinical Trials in Phase 2 Or 2/1B
3.8.4 Clinical Trials in Phase
3.8.5 Clinical Trials in Early Phase
3.6 Regulatory Farnework Analysis
3.7 Reimbursement Policy Analysis
CHAPTER 4 SMART PILLS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
4.1 How Smart Pills work
4.2 Mechanism of Capsule endoscope
4.3 Smart Pills Market: Application Movement Analysis
4.4 Smart Pills Market: Application Movement Analysis
4.5 Product
4.5.1 Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
4.5.2 Capsule Endoscopy
4.5.2.1 Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
4.5.3 Drug delivery
4.5.3.1 Market Estimate & Segment Forecast, 2014 - 2025 (USD Million)
4.6 Tools
4.6.1 Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
4.7 Patient Monitoring
4.7.1 Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
CHAPTER 5 SMART PILLS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY DISEASES
5.1 Smart Pills: Region Movement Analysis
5.2 Global Smart Pills Market Share by Region
5.3 North America
5.3.1 Market estimates and forecasts, 2014 - 2025
5.3.2 U.S.
5.3.2.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.3.2.2 Market estimates and forecasts, (by Product) 2014 - 2025
5.3.3 Canada
5.3.3.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.3.3.2 Market estimates and forecasts, (by Product) 2014 - 2025
5.4 Europe
5.4.1 Europe smart pills market estimates and forecasts, 2014 - 2025
5.4.2 U.K.
5.4.2.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.4.2.2 Market estimates and forecasts, (by Product) 2014 - 2025
5.4.3 Germany
5.4.3.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.4.3.2 Market estimates and forecasts, (by Product) 2014 - 2025
5.5 Asia Pacific
5.5.1 Asia Pacific smart pills market estimates and forecasts, 2014 - 2025
5.5.2 Japan
5.5.2.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.5.2.2 Market estimates and forecasts, (by Product) 2014 - 2025
5.5.3 China
5.5.3.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.5.3.2 Market estimates and forecasts, (by Product) 2014 - 2025
5.6 Latin America
5.6.1 Latin America smart pills market estimates and forecasts, 2014 - 2025
5.6.2 Brazil
5.6.2.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.6.2.2 Market estimates and forecasts, (by Product) 2014 - 2025
5.6.3 Mexico
5.6.3.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.6.3.2 Market estimates and forecasts, (by Product) 2014 - 2025
5.7 Middle East and Africa (MEA)
5.7.1 MEA smart pills market estimates and forecasts, 2014 - 2025
5.7.2 South Africa
5.7.2.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.7.2.2 Market estimates and forecasts, (by Product) 2014 - 2025
CHAPTER 6 COMPETITIVE LANDSCAPE
6.1 Market Participation Categorization
6.2 Company Profiles
6.2.1 Medtronic
6.2.1.1 Company overview
6.2.1.2 Financial performance (USD Million)
6.2.1.3 Product benchmarking
6.2.1.4 Strategic initiatives
6.2.2 Proteus Digital Health (Subsidiary of Harbin Gloria Pharmaceuticals Company Ltd.)
6.2.2.1 Company overview
6.2.2.2 Financial performance(USD Million)
6.2.2.3 Product benchmarking
6.2.2.4 Strategic initiatives
6.2.3 CapsoVision, Inc.
6.2.3.1 Company overview
6.2.3.2 Financial performance
6.2.3.3 Product benchmarking
6.2.3.4 Strategic initiatives
6.2.4 Olympus Corporation
6.2.4.1 Company overview
6.2.4.2 Financial performance
6.2.4.3 Product benchmarking
6.2.5 Medisafe
6.2.5.1 Company overview
6.2.5.2 Financial performance
6.2.5.3 Product benchmarking
6.2.5.4 Strategic initiatives
1.1 Market segmentation & scope
CHAPTER 2 RESEARCH METHODOLOGY
2.1 Information procurement
2.2 Data Analysis
2.3 Approaches for market estimation
2.3.1 Approach 1: Demand Analysis & Bottom up Approach
2.3.2 Approach 2: Top down market estimation
2.3.3 Approach 3: Commodity flow and bottom up market estimation
2.3.4 Approach 4: KoL perspective based market sizing
CHAPTER 3 SMART PILLS MARKET VARIABLES, TRENDS, & SCOPE
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.1.1 Increasing incidences of diseases such colorectal cancer and gastrointestinal disorders
3.1.1.2 Increasing geographical reach by major market players
3.1.1.3 FDA approvals and CE Mark for smart pills
3.1.1.4 High Cancer screening awareness programs
3.1.2 Market Restraint Analysis
3.1.2.1 Technological limitations
3.1.2.2 Lengthy product approval process
3.1.2.3 Risks associated with the Capsule endoscopy procedures
3.2 Penetration & growth prospect mapping
3.3 Smart Pills - SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.4 Industry Analysis - Porter’s
3.5 Pipeline Development and Clinical Trials
3.8.1 Clinical Trials in Phase
3.8.2 Clinical Trials in Phase 3 Or 3/2B
3.8.3 Clinical Trials in Phase 2 Or 2/1B
3.8.4 Clinical Trials in Phase
3.8.5 Clinical Trials in Early Phase
3.6 Regulatory Farnework Analysis
3.7 Reimbursement Policy Analysis
CHAPTER 4 SMART PILLS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
4.1 How Smart Pills work
4.2 Mechanism of Capsule endoscope
4.3 Smart Pills Market: Application Movement Analysis
4.4 Smart Pills Market: Application Movement Analysis
4.5 Product
4.5.1 Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
4.5.2 Capsule Endoscopy
4.5.2.1 Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
4.5.3 Drug delivery
4.5.3.1 Market Estimate & Segment Forecast, 2014 - 2025 (USD Million)
4.6 Tools
4.6.1 Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
4.7 Patient Monitoring
4.7.1 Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
CHAPTER 5 SMART PILLS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY DISEASES
5.1 Smart Pills: Region Movement Analysis
5.2 Global Smart Pills Market Share by Region
5.3 North America
5.3.1 Market estimates and forecasts, 2014 - 2025
5.3.2 U.S.
5.3.2.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.3.2.2 Market estimates and forecasts, (by Product) 2014 - 2025
5.3.3 Canada
5.3.3.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.3.3.2 Market estimates and forecasts, (by Product) 2014 - 2025
5.4 Europe
5.4.1 Europe smart pills market estimates and forecasts, 2014 - 2025
5.4.2 U.K.
5.4.2.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.4.2.2 Market estimates and forecasts, (by Product) 2014 - 2025
5.4.3 Germany
5.4.3.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.4.3.2 Market estimates and forecasts, (by Product) 2014 - 2025
5.5 Asia Pacific
5.5.1 Asia Pacific smart pills market estimates and forecasts, 2014 - 2025
5.5.2 Japan
5.5.2.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.5.2.2 Market estimates and forecasts, (by Product) 2014 - 2025
5.5.3 China
5.5.3.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.5.3.2 Market estimates and forecasts, (by Product) 2014 - 2025
5.6 Latin America
5.6.1 Latin America smart pills market estimates and forecasts, 2014 - 2025
5.6.2 Brazil
5.6.2.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.6.2.2 Market estimates and forecasts, (by Product) 2014 - 2025
5.6.3 Mexico
5.6.3.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.6.3.2 Market estimates and forecasts, (by Product) 2014 - 2025
5.7 Middle East and Africa (MEA)
5.7.1 MEA smart pills market estimates and forecasts, 2014 - 2025
5.7.2 South Africa
5.7.2.1 Market estimates and forecasts, (by Application) 2014 - 2025
5.7.2.2 Market estimates and forecasts, (by Product) 2014 - 2025
CHAPTER 6 COMPETITIVE LANDSCAPE
6.1 Market Participation Categorization
6.2 Company Profiles
6.2.1 Medtronic
6.2.1.1 Company overview
6.2.1.2 Financial performance (USD Million)
6.2.1.3 Product benchmarking
6.2.1.4 Strategic initiatives
6.2.2 Proteus Digital Health (Subsidiary of Harbin Gloria Pharmaceuticals Company Ltd.)
6.2.2.1 Company overview
6.2.2.2 Financial performance(USD Million)
6.2.2.3 Product benchmarking
6.2.2.4 Strategic initiatives
6.2.3 CapsoVision, Inc.
6.2.3.1 Company overview
6.2.3.2 Financial performance
6.2.3.3 Product benchmarking
6.2.3.4 Strategic initiatives
6.2.4 Olympus Corporation
6.2.4.1 Company overview
6.2.4.2 Financial performance
6.2.4.3 Product benchmarking
6.2.5 Medisafe
6.2.5.1 Company overview
6.2.5.2 Financial performance
6.2.5.3 Product benchmarking
6.2.5.4 Strategic initiatives
LIST OF TABLES
Table 1 North America smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 2 North America smart pills market, by Product, 2014 - 2025 (USD Million)
Table 3 U.S. smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 4 U.S. smart pills market, by Product, 2014 - 2025 (USD Million)
Table 5 Canada smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 6 Canada smart pills market, by Product, 2014 - 2025 (USD Million)
Table 7 Europe smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 8 Europe smart pills market, by Product, 2014 - 2025 (USD Million)
Table 9 U.K. smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 10 U.K. smart pills market, by Product, 2014 - 2025 (USD Million)
Table 11 Germany smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 12 Germany smart pills market, by Product, 2014 - 2025 (USD Million)
Table 13 Asia Pacific smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 14 Asia Pacific smart pills market, by Product, 2014 - 2025 (USD Million)
Table 15 Japan smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 16 Japan smart pills market, by Product, 2014 - 2025 (USD Million)
Table 17 China smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 18 China smart pills market, by Product, 2014 - 2025 (USD Million)
Table 19 Latin America smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 20 Latin America smart pills market, by Product, 2014 - 2025 (USD Million)
Table 21 Brazil smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 22 Brazil smart pills market, by Product, 2014 - 2025 (USD Million)
Table 23 Mexico smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 24 Mexico smart pills market, by Product, 2014 - 2025 (USD Million)
Table 25 MEA smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 26 MEA smart pills market, by Product, 2014 - 2025 (USD Million)
Table 27 South Africa smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 28 South Africa smart pills market, by Product, 2014 - 2025 (USD Million)
Table 1 North America smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 2 North America smart pills market, by Product, 2014 - 2025 (USD Million)
Table 3 U.S. smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 4 U.S. smart pills market, by Product, 2014 - 2025 (USD Million)
Table 5 Canada smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 6 Canada smart pills market, by Product, 2014 - 2025 (USD Million)
Table 7 Europe smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 8 Europe smart pills market, by Product, 2014 - 2025 (USD Million)
Table 9 U.K. smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 10 U.K. smart pills market, by Product, 2014 - 2025 (USD Million)
Table 11 Germany smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 12 Germany smart pills market, by Product, 2014 - 2025 (USD Million)
Table 13 Asia Pacific smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 14 Asia Pacific smart pills market, by Product, 2014 - 2025 (USD Million)
Table 15 Japan smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 16 Japan smart pills market, by Product, 2014 - 2025 (USD Million)
Table 17 China smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 18 China smart pills market, by Product, 2014 - 2025 (USD Million)
Table 19 Latin America smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 20 Latin America smart pills market, by Product, 2014 - 2025 (USD Million)
Table 21 Brazil smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 22 Brazil smart pills market, by Product, 2014 - 2025 (USD Million)
Table 23 Mexico smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 24 Mexico smart pills market, by Product, 2014 - 2025 (USD Million)
Table 25 MEA smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 26 MEA smart pills market, by Product, 2014 - 2025 (USD Million)
Table 27 South Africa smart pills market, by Application type, 2014 - 2025 (USD Million)
Table 28 South Africa smart pills market, by Product, 2014 - 2025 (USD Million)
LIST OF FIGURES
Fig. 1 Market summary (USD Million), 2016
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market trends & outlook
Fig. 9 Market segmentation & scope
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping
Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Smart Pills market: Application outlook key takeaways
Fig. 16 How Smart Pills Work
Fig. 17 Mechanism of Capsule Endoscope
Fig. 18 Smart Pills: Application movement analysis
Fig. 19 Product Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
Fig. 20 Capsule Endoscopy Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
Fig. 21 Drug Delivery Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
Fig. 22 Tools Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
Fig. 23 Patient Monitoring Software Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
Fig. 24 Regional market place: Key takeaways
Fig. 25 Smart Pills: Region movement analysis
Fig. 26 Regional outlook, 2016 & 2025
Fig. 27 North America smart pills market, 2014 - 2025 (USD Million)
Fig. 28 U.S. smart pills market, 2014 - 2025 (USD Million)
Fig. 29 Canada smart pills market, 2014 - 2025 (USD Million)
Fig. 30 Europe smart pills market, 2014 - 2025 (USD Million)
Fig. 31 Government Healthcare Expenditure in U.K.: percent of GDP (Gross Domestic Product)
Fig. 32 U.K. smart pills market, 2014 - 2025 (USD Million)
Fig. 33 Germany smart pills market, 2014 - 2025 (USD Million)
Fig. 34 Asia Pacific smart pills market, 2014 - 2025 (USD Million)
Fig. 35 Japan smart pills market, 2014 - 2025 (USD Million)
Fig. 36 China disposable income per capita (2007- 2016), USD million
Fig. 37 China government health expenditure (2005- 2015), USD million
Fig. 38 China smart pills market, 2014 - 2025 (USD Million)
Fig. 39 Latin America smart pills market, 2014 - 2025 (USD Million)
Fig. 40 Brazil, foreign Direct Investment, Net inflows % of GDP
Fig. 41 Brazil, consumer spending, 2013-2018 (USD)
Fig. 42 Brazil smart pills market, 2014 - 2025 (USD Million)
Fig. 43 Mexico smart pills market, 2014 - 2025 (USD Million)
Fig. 44 MEA smart pills market, 2014 - 2025 (USD Million)
Fig. 45 South Africa smart pills market, 2014 - 2025 (USD Million)
Fig. 46 Participant categorization
Fig. 1 Market summary (USD Million), 2016
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market trends & outlook
Fig. 9 Market segmentation & scope
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping
Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Smart Pills market: Application outlook key takeaways
Fig. 16 How Smart Pills Work
Fig. 17 Mechanism of Capsule Endoscope
Fig. 18 Smart Pills: Application movement analysis
Fig. 19 Product Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
Fig. 20 Capsule Endoscopy Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
Fig. 21 Drug Delivery Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
Fig. 22 Tools Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
Fig. 23 Patient Monitoring Software Market Estimates & Segment Forecast, 2014 - 2025 (USD Million)
Fig. 24 Regional market place: Key takeaways
Fig. 25 Smart Pills: Region movement analysis
Fig. 26 Regional outlook, 2016 & 2025
Fig. 27 North America smart pills market, 2014 - 2025 (USD Million)
Fig. 28 U.S. smart pills market, 2014 - 2025 (USD Million)
Fig. 29 Canada smart pills market, 2014 - 2025 (USD Million)
Fig. 30 Europe smart pills market, 2014 - 2025 (USD Million)
Fig. 31 Government Healthcare Expenditure in U.K.: percent of GDP (Gross Domestic Product)
Fig. 32 U.K. smart pills market, 2014 - 2025 (USD Million)
Fig. 33 Germany smart pills market, 2014 - 2025 (USD Million)
Fig. 34 Asia Pacific smart pills market, 2014 - 2025 (USD Million)
Fig. 35 Japan smart pills market, 2014 - 2025 (USD Million)
Fig. 36 China disposable income per capita (2007- 2016), USD million
Fig. 37 China government health expenditure (2005- 2015), USD million
Fig. 38 China smart pills market, 2014 - 2025 (USD Million)
Fig. 39 Latin America smart pills market, 2014 - 2025 (USD Million)
Fig. 40 Brazil, foreign Direct Investment, Net inflows % of GDP
Fig. 41 Brazil, consumer spending, 2013-2018 (USD)
Fig. 42 Brazil smart pills market, 2014 - 2025 (USD Million)
Fig. 43 Mexico smart pills market, 2014 - 2025 (USD Million)
Fig. 44 MEA smart pills market, 2014 - 2025 (USD Million)
Fig. 45 South Africa smart pills market, 2014 - 2025 (USD Million)
Fig. 46 Participant categorization
